Access to raw materials is clearly essential for all parties. Chemical manufacturers therefore work closely with both generics and R&D organisations to develop APIs and intermediates for generating new generics, branded generics or branded products. Trading on tighter profit margins than most, the chemical industry faces the constant challenge of understanding the current market, future requirements and whether products can be developed to the prerequisite standard.
Production efficiency
Demand planning is the optimal approach to ensuring production efficiency. IMS is developing further tools to help chemical companies address certain key areas of efficiency in their business:
- What is the likely demand for this product?
- When will stock be required?
- What are ideal lead times for manufacture?
- Where do we source the intermediates?
- Should manufacturing be done in-house or outsourced
- What cost model is optimal for ROI?
Trade (wholesalers and pharmacists)
Generics medicines have played a crucial role in the trade dynamics mix and driven much of the profitability seen today in the market. Sometimes considered a commodity, generics trading has been highly successful not only domestically within countries but also across borders. So much so, that measuring actual demand levels and the movement of generics is a critical area, and IMS works closely with trade partners and clients to address this.
Performance management
IMS has a suite of solutions for supply stakeholders with issues around benchmarking, monitoring, sourcing opportunities and strategic market insights.
